AxoGen, Inc. Stock News
$43.83
1.18%
Nasdaq, Sep 25, 10:02 am EDT.
Market open.
Index
Industry
AxoGen, Inc. Stock News
ALACHUA, Fla. and TAMPA, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the pricing of an underwritten public offering of 4,910,000 shares of its common stock at a price to the public of $42.50 per share, b...
Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen's addressable market within its focus markets
ALACHUA, Fla. and TAMPA, Fla.
AxoGen, Stock Of the Day, is flashing a buy signal. Ten out of 10 analysts are bullish about AxoGen after strong earnings and raised 2026 guidance.
ALACHUA, Fla. and TAMPA, Fla.
ALACHUA, Fla. and TAMPA, Fla.
ALACHUA, Fla. and TAMPA, Fla.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
